Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)
Operating Income Growth
-8.93%
TTM · Period ending:
CANF Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-8.93%period ending
Latest reported-8.93%period ending
CANF TTM Operating Income YoY % (-5.33% → -8.93%)
Year-over-year change
High-resolution chart · PNG
CANF operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -8.9322% | |
| -15.3423% | |
| -22.3863% | |
| -18.8271% | |
| -14.6413% | |
| -13.3067% | |
| 0.7932% | |
| 15.8619% | |
| 23.2368% | |
| 27.8597% | |
| 19.8455% | |
| 15.4445% | |
| 16.1408% | |
| 20.7381% | |
| 20.3862% | |
| 9.6871% | |
| -6.7925% | |
| -9.4316% | |
| 9.1732% | |
| 18.6007% | |
| 26.8881% | |
| 17.3943% | |
| -17.7956% | |
| -53.4801% | |
| -14.2257% | |
| -15.1894% | |
| 4.16% | |
| 20.293% | |
| -90.6179% | |
| -80.1307% | |
| -69.8007% | |
| -64.0703% | |
| 17.901% | |
| 21.3724% | |
| 14.5723% | |
| 10.1813% | |
| -15.6593% | |
| -30.3952% | |
| -34.5885% | |
| -48.1349% | |
| -31.0702% | |
| -6.775% | |
| 10.058% | |
| 36.2029% | |
| 37.072% | |
| 29.6096% | |
| 19.8693% | |
| -18.1208% | |
| -26.3202% | |
| -45.4074% | |
| -45.7794% | |
| -45.9689% | |
| -43.3455% | |
| -24.4726% | |
| -22.557% | |
| -4.6086% | |
| -5.3293% |